NEW YORK--(BUSINESS WIRE)--The Sagemark Companies Ltd (OTCBB:SKCO), a national owner and operator of outpatient medical diagnostic imaging centers that utilize positron emission tomography (PET) and PET and computed tomography (PET/CT), announced today that as a complement to its existing operations, it is entering the cancer treatment field deploying an advanced radiation therapy system developed by TomoTherapy Incorporated (Nasdaq: TTPY).
